Evonik Industries AG Stock
€18.61
Your prediction
Evonik Industries AG Stock
Pros and Cons of Evonik Industries AG in the next few years
Pros
Cons
Performance of Evonik Industries AG vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Evonik Industries AG | -0.160% | -3.719% | -7.171% | 0.350% | 11.151% | -18.030% | -19.412% |
| Brenntag SE | 0.670% | -3.915% | -1.656% | -8.333% | 2.238% | -12.441% | 27.358% |
| Lanxess AG | -0.080% | -7.598% | -6.652% | 17.102% | 8.681% | -33.472% | -45.439% |
| Avient Corp. | -1.330% | -8.537% | -11.243% | -25.373% | -21.875% | -20.635% | 29.310% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.After reviewing the financial statements of Evonik, a leading chemicals company, the general impression is that of a stable and growing business. The company has shown improvements in certain key performance indicators over the years, while also facing a few challenges, typical of the industry in which it operates.
Increased Total Assets: Evonik's total assets have grown consistently from €20.9 billion in 2020 to €22.2 billion in 2021 and further to €21.8 billion in 2022. This suggests that the company is actively expanding its business operations and enhancing its capacity.
Strong Gross Profit: The company's gross profit consistently increased from €3.37 billion in 2020 to €4.23 billion in 2022. These values demonstrate the company's ability to generate profit from its core business operations before accounting for other expenses.
